PA8447901A1 - Metodo de uso de carbamatos y ureas neurotropicos - Google Patents

Metodo de uso de carbamatos y ureas neurotropicos

Info

Publication number
PA8447901A1
PA8447901A1 PA19988447901A PA8447901A PA8447901A1 PA 8447901 A1 PA8447901 A1 PA 8447901A1 PA 19988447901 A PA19988447901 A PA 19988447901A PA 8447901 A PA8447901 A PA 8447901A PA 8447901 A1 PA8447901 A1 PA 8447901A1
Authority
PA
Panama
Prior art keywords
ureas
carbamates
neurotropic
immunifilines
peptidil
Prior art date
Application number
PA19988447901A
Other languages
English (en)
Spanish (es)
Inventor
Jia-He Li
Gregory Hamilton
Joseph P Steiner
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Publication of PA8447901A1 publication Critical patent/PA8447901A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PA19988447901A 1997-02-27 1998-02-26 Metodo de uso de carbamatos y ureas neurotropicos PA8447901A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80564697A 1997-02-27 1997-02-27

Publications (1)

Publication Number Publication Date
PA8447901A1 true PA8447901A1 (es) 2000-05-24

Family

ID=25192108

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988447901A PA8447901A1 (es) 1997-02-27 1998-02-26 Metodo de uso de carbamatos y ureas neurotropicos

Country Status (9)

Country Link
EP (1) EP1001762A4 (xx)
JP (1) JP2001513772A (xx)
AR (1) AR011869A1 (xx)
AU (1) AU6181698A (xx)
CA (1) CA2281096A1 (xx)
PA (1) PA8447901A1 (xx)
PE (1) PE46599A1 (xx)
WO (1) WO1998037882A1 (xx)
ZA (1) ZA98825B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218424B1 (en) * 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
US6242468B1 (en) * 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
AU756912B2 (en) 1998-07-17 2003-01-23 Agouron Pharmaceuticals, Inc. Compounds, compositions, and methods for stimulating neuronal growth and elongation
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US7338976B1 (en) * 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6323215B1 (en) 1999-07-09 2001-11-27 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
JP2003504367A (ja) 1999-07-09 2003-02-04 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 神経栄養性ピロリジン類およびピペリジン類、並びに関連組成物および方法
WO2001004091A1 (en) 1999-07-09 2001-01-18 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
CA2383086A1 (en) * 1999-09-08 2001-03-15 Joseph P. Steiner Non-peptidic cyclophilin binding compounds and their use
GT200000203A (es) 1999-12-01 2002-05-24 Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas.
EP1339668A2 (en) * 2000-11-28 2003-09-03 Guilford Pharmaceuticals Inc. Bisubstituted carbocyclic cyclophilin binding compounds and theirus
US6656971B2 (en) * 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
EP1402888A1 (en) * 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620971A (en) * 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) * 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds

Also Published As

Publication number Publication date
AR011869A1 (es) 2000-09-13
CA2281096A1 (en) 1998-09-03
WO1998037882A1 (en) 1998-09-03
PE46599A1 (es) 1999-05-12
EP1001762A1 (en) 2000-05-24
ZA98825B (en) 1998-10-19
EP1001762A4 (en) 2002-05-08
JP2001513772A (ja) 2001-09-04
AU6181698A (en) 1998-09-18

Similar Documents

Publication Publication Date Title
PA8446601A1 (es) Metodo de uso de compuestos neurotropicos de sulfonamidas
PA8447901A1 (es) Metodo de uso de carbamatos y ureas neurotropicos
PA8438501A1 (es) Esteres y amidas heterociclicos
PA8444001A1 (es) Ureas y carbamatos de tioesteres heterociclicos con enlace n
PA8438401A1 (es) Tiosteres y cetonas heterociclicos
EA199900162A1 (ru) Ингибиторы клеточной адгезии
BR9713732A (pt) Sulfonamidas de tioésteres heterocìclicos ligadas pelo nitrogênio
PT1091975E (pt) Nova ciclosporina com um perfil de actividade melhorado
PA8448001A1 (es) N-oxidos de esteres heterociclicos, amidas, tioesteres,y cetonas
PT1282620E (pt) Carbamatos azabiciclicos e sua utilizacao como agonistas de receptores nicotinicos alfa-7 de acetilcolina
ATE485366T1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
NO20015096L (no) Måling og bruk av molekul¶re interaksjoner
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
ATE346168T1 (de) Funktionelles oberflächendisplay von polypeptiden
ATE421584T1 (de) Cpg rezeptor (cpg-r) und darauf bezogene methoden
PA8443901A1 (es) Sulfonamidas de tioesteres heterociclicos con enlace n
PA8442401A1 (es) Inhibidores polipropilos de ciclofilina
BR9912988A (pt) Composição farmacêutica e método de desenvolvimento de atividade neuronial em animal
ECSP982416A (es) Metodo de uso de carbamatos y ureas neurotropicos
ATE280836T1 (de) Test zur gleichzeitigen messung von verschiedenen enzymatischen aktivitäten
NO992751L (no) N-bundet urinstoffer og karbamater av heterocykliske tioestere
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
ECSP982403A (es) Metodo de uso de compuestos neurotropicos de sulfonamidas
GT199800023A (es) Metodo para usar carbamatos neurotroficos y ureas.
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики